Antitumor and antimetastatic activities of vesicular stomatitis virus matrix protein in a murine model of breast cancer

Journal of Molecular Medicine

Volumn 87, Issue 5, 2009, Pages 493-506

  Shi, Wei ^a   Tang, Qingqing ^a   Chen, Xiancheng ^a   Cheng, Ping ^a   Jiang, Peidu ^a   Jing, Xiaomei ^a   Chen, Xiang ^a   Chen, Ping ^a   Wang, Yongsheng ^a   Wei, Yuquan ^a   Wen, Yanjun ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

4T1 mammary tumor; Apoptosis; DOTAP:Chol; Metastases; Vesicular stomatitis virus matrix protein

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; CHOLESTEROL; GELATINASE B; MATRIX PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER GENE THERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; LIPOSOMAL GENE DELIVERY SYSTEM; LUNG METASTASIS; METASTASIS INHIBITION; MORPHOMETRICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RECOMBINANT PLASMID; TREATMENT DURATION; VESICULAR STOMATITIS VIRUS;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOOD VESSELS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR BURDEN; VIRAL MATRIX PROTEINS;

EID: 67349240200     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-009-0444-5     Document Type: Article

References (50)

1. World Health organization (February 2006) Fact sheet No 297: Cancer
2. GN Hortobagyi 1998 Treatment of breast cancer N Engl J Med 339 974 984 (Pubitemid 28455101)
3. DL Dexter HM Kowalski BA Blazar Z Fligiel R Vogel GH Heppner 1978 Heterogeneity of tumor cells from a single mouse mammary tumor Cancer Res 38 3174 3181 (Pubitemid 9031291)
4. CJ Aslakson FR Miller 1992 Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor Cancer Res 52 1399 1405
5. BA Pulaski SO Rosenberg 1998 Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B 7.1 cell-based tumor vaccines Cancer Res 58 1486 1493 (Pubitemid 28193612)
6. BA Pulaski DS Terman S Khan 2000 Cooperativity of staphylococcal aureus entertoxin B superantigen, Major Histocompatibility Complex Class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model Cancer Res 60 2710 2715 (Pubitemid 30318248)
7. J Yang SA Mani JL Donaher 2004 Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis Cell 117 927 939 (Pubitemid 38798858)
8. DF Stojdl B Lichty S Knowles 2000 Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus Nat Med 6 821 825 (Pubitemid 30469434)
9. S Balachandran GN Barber 2004 Defective translational control facilitates vesicular stomatitis virus oncolysis Cancer Cell 5 51 65 (Pubitemid 38121596)
10. S Balachandran GN Barber 2000 Vesicular stomatitis virus (VSV) therapy of tumors IUBMB Life 50 135 138
11. S Balachandran M Porosnicu GN Barber 2001 Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis J Virol 75 3474 3479 (Pubitemid 32225911)
12. DF Stojdl BD Lichty BR tenOever 2003 VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents Cancer Cell 4 263 275 (Pubitemid 37329791)
13. K Shinozaki O Ebert C Koumioti 2004 Oncolysis of multifocal hepatocellular carcinoma in the rat liver by hepatic artery infusion of vesicular stomatitis virus Mol Ther 9 368 376 (Pubitemid 38404525)
14. M Ahmed SD Cramer DS Lyles 2004 Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses Virol 330 34 49 (Pubitemid 39446565)
15. Q Li YQ Wei 2004 Induction of apoptosis and tumor regression by vesicular stomatitis virus in the presence of gemcitabine in lung cancer Int J Cancer 112 143 149 (Pubitemid 39249502)
16. O Ebert S Harbaran K Shinozaki SL Woo 2005 Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice Cancer Gen Ther. 12 350 358 (Pubitemid 40411194)
17. DF Gaddy DS Lyles 2007 Oncolytic vesicular stomatitis virus induces apoptosis via signaling through PKR, FAS, and Daxx J Virol 81 2792 2804 (Pubitemid 46447043)
18. GJ Letchworth LL Rodriguez CBJ Del 1999 Vesicular stomatitis Vet J 157 239 60 (Pubitemid 129524048)
19. Z Bi P Quandt T Komatsu M Barna CS Reiss 1995 IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system J Immunol 155 5684 5689
20. d system J Virol 65 4950 4958
21. BS Huneycutt Z Bi CJ Aoki CS Reiss 1993 Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice J Virol 67 6698 6706 (Pubitemid 23309138)
22. BS Huneycutt IV Plakhov Z Shusterman SM Bartido A Huang CS Reiss C Aoki 1994 Distribution of vesicular stomatitis virus proteins in the brains of BALB/c mice following intranasal inoculation: an immunohistochemical analysis Brain Res 635 81 95 (Pubitemid 24031391)
23. B Lundh K Kristensson E Norrby 1987 Selective infections of olfactory and respiratory epithelium by vesicular stomatitis and Sendai viruses Neuropathol Appl Neurobiol 13 111 122 (Pubitemid 17115922)
24. IV Plakhov EE Arlund C Aoki CS Reiss 1995 The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system Virol 209 257 262
25. JH Sur R Allende 2003 Vesicular stomatitis virus infection and neuropathogenesis in the murine model are associated with apoptosis Vet Pathol 40 512 520 (Pubitemid 38393557)
26. BL Black DS Lyles 1992 Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo J Virol 66 4058 64
27. BL Black RB Rhodes M McKenzie DS Lyles 1993 The role of vesicular stomatitis virus matrix protein in inhibition of host-directed gene expression is genetically separable from its function in virus assembly J Virol 67 4814 21 (Pubitemid 23215962)
28. SY Paik AC Banerjea GG Harmison CJ Chen M Schubert 1995 Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis matrix protein J Virol 69 3529 3537
29. MC Ferran JM Lucas-Lenard 1997 The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter J Virol 71 371 377 (Pubitemid 26412301)
30. M Ahmed DS Lyles 1998 Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III J Virol 72 8413 9 (Pubitemid 28421849)
31. H Yuan BK Yoza DS Lyles 1998 Inhibition of host RNA polymerase II-dependent transcription by vesicular stomatitis virus results from inactivation of TFIID Virol 251 83 92 (Pubitemid 28535907)
32. H Yuan S Puckett DS Lyles 2001 Inhibition of host transcription by vesicular stomatitis virus involves a novel mechanism that is independent of phosphorylation of TATA-binding protein (TBP) or association of TBP with TBP-associated factor subunits J Virol 75 4453 4458 (Pubitemid 32410163)
33. M Ahmed MO McKenzie S Puckett 2003 Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis J Virol 77 4646 4657 (Pubitemid 36402814)
34. LS Her E Lund JE Dahlberg 1997 Inhibition of Ran guanosine triphosphatase dependent nuclear transport by the matrix protein of vesicular stomatitis virus Science 276 1845 1848 (Pubitemid 27443658)
35. JM Petersen LS Her V Varvel 2000 The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes Mol Cell Biol 20 8590 8601
36. CV Kobbe JMV Deursen JP Rodrigues D Sitterlin A Bachi X Wu M Wilm M Carmo-Fonseca E Izaurralde 2000 Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98 Mol Cell 6 1243 252
37. NS Templeton DD Lasic PM Frederik 1997 Improved DNA:liposome complexes for increased systemic delivery and gene expression Nat Biotech 15 647 652 (Pubitemid 27291165)
38. I Ito G Began I Mohiuddin 2003 Increased uptake of liposome-DNA complexes by lung metastases following intravenous administration Mol Ther 7 409 418 (Pubitemid 36503865)
39. JC Bell B Lichty D Stojdl 2003 Getting oncolytic virus therapies off the ground Cancer Cell 4 7 11 (Pubitemid 36904156)
40. G Thurston 1998 Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice J Clin Invest 101 1401 1413 (Pubitemid 28166838)
41. Q Zhong YJ Wen X Zhao 2008 Efficient inhibition of cisplatin-resistant human ovarian cancer growth and prolonged survival by gene transferred vesicular stomatitis virus matrix protein in nude mice Ann Oncol 19 1584 1591
42. WM Siders K Vergillis C Johnson RK Scheule JM Kaplan 2002 Tumor treatment with complexes of cationic lipid and noncoding plasmid DNA results in the induction of cytotoxic T cells and systemic tumor elimination Mol Ther 6 519 27 (Pubitemid 35214874)
43. MD Sternlicht Z Werb 2001 How matrix metalloproteinases regulate cell behavior Annu. Rev Cell. Dev Biol 17 307 323 (Pubitemid 33096184)
44. M Egeblad Z Werb 2002 New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2 161 174 (Pubitemid 37328786)
45. L Hlatky P Hahnfeldt J Folkman 2002 Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us J N C I 94 883 893
46. D Shweiki A Itin D Soffer E Keshet 1992 Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 359 843 845
47. JA Berzofsky M Terabe SK Oh IM Belyakov JD Ahlers JE Janik JC Morris 2004 Progress on new vaccine strategies for the immunotherapy and prevention of cancer J Clin Invest 113 1515 1525 (Pubitemid 39071672)
48. JY Liu YQ Wei L Yang 2003 Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2 Blood 102 1815 1823 (Pubitemid 37022578)
49. Y Lu YQ Wei L Tian 2003 Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor J Immunol 170 3162 3170 (Pubitemid 36302193)
50. N Weidner JP Semple WR Welch J Folkman 1991 Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma N Engl J Med 324 1 8